The Limit of Detection (LoD) is the lowest concentration of an analyte—such as circulating tumor DNA (ctDNA)—that an assay can reliably distinguish from background noise at a specified confidence level, typically 95%. It is empirically determined by measuring replicates of a blank sample and a low-concentration sample, then calculating the signal threshold above which a positive detection is statistically distinct from zero. LoD is distinct from the Limit of Quantification (LoQ), which defines the lowest concentration measurable with acceptable precision and accuracy.
Glossary
Limit of Detection (LoD)

What is Limit of Detection (LoD)?
The Limit of Detection (LoD) defines the lowest analyte concentration that can be reliably distinguished from the absence of that analyte (a blank sample) with a defined statistical confidence, establishing the analytical sensitivity floor of a measurement procedure.
In liquid biopsy analytics, LoD is often expressed as the minimum Variant Allele Frequency (VAF) detectable in a cell-free DNA sample, frequently targeting 0.1% or lower for early cancer detection. Achieving an ultra-low LoD requires error-suppression techniques such as Unique Molecular Identifiers (UMIs) and duplex sequencing to distinguish true somatic variants from polymerase errors and base damage. The LoD directly constrains clinical sensitivity, as a tumor must shed sufficient ctDNA to exceed this threshold for a positive result.
Key Determinants of LoD in Liquid Biopsy
The Limit of Detection (LoD) is not a single fixed number but a dynamic threshold governed by the interplay of molecular biology, sequencing chemistry, and computational noise suppression. The following factors collectively define the lowest concentration of analyte that can be reliably distinguished from background noise.
Input Molecule Quantity
The absolute number of amplifiable genome equivalents (GE) extracted from plasma is the fundamental ceiling on sensitivity. LoD is mathematically constrained by Poisson sampling statistics: if a mutation is present at 0.1% VAF, a minimum of ~3,000 GE must be interrogated to reliably capture at least one mutant molecule. Low-yield extractions from limited plasma volumes directly degrade the assay's ability to resolve rare variants, regardless of downstream error correction.
Background Error Rate
The systematic noise floor of the assay, arising from polymerase errors during library amplification, oxidative DNA damage, and sequencer base-calling inaccuracies. A variant is only detectable when its signal exceeds this noise. Standard NGS workflows exhibit error rates of ~0.1–1%, which obscures low-frequency ctDNA. Reducing this rate via molecular barcoding and specialized polymerases is the primary engineering challenge for improving LoD.
Sequencing Depth & Breadth
Dedicated sequencing depth—the number of times a given base is read—is directly proportional to the power to resolve low-frequency variants. To confidently call a variant at 0.01% VAF, a unique depth of >10,000x is typically required after deduplication. This often necessitates targeted panel sequencing rather than whole-genome approaches, trading genomic breadth for the extreme depth necessary to achieve a clinically actionable LoD.
Allelic Dropout & Sampling Bias
A stochastic phenomenon where a true variant molecule is not captured, amplified, or sequenced due to chance. This is most severe at very low input quantities and can cause false negatives even when the mean expected number of mutant molecules is >1. LoD calculations must account for the probability of dropout, often modeled via binomial or Poisson statistics, to define the concentration at which a variant is detected with 95% confidence.
Computational Noise Filtering
Bioinformatic pipelines apply a series of filters to distinguish signal from artifact. Key steps include:
- Base Quality Recalibration (BQR): Adjusts sequencer quality scores using machine learning models of error covariates.
- Panel of Normals (PoN): Suppresses recurrent technical artifacts identified in healthy control samples.
- Germline Filtering: Subtracts inherited polymorphisms using matched normal DNA or population databases.
- Positional Bias Models: Corrects for strand-specific and cycle-specific errors. The rigor of these filters directly impacts the achievable LoD.
Frequently Asked Questions
Clarifying the statistical and practical boundaries of detecting rare biomarkers in a high-background environment.
The Limit of Detection (LoD) is the lowest concentration of an analyte—such as circulating tumor DNA (ctDNA) or a specific somatic variant—that can be reliably distinguished from background noise with a defined statistical confidence, typically 95%. It defines the analytical sensitivity floor of the assay. Unlike the Limit of Blank (LoB), which characterizes the signal distribution of negative control samples, the LoD is established by serially diluting a known positive sample into a negative matrix until the signal is no longer consistently distinguishable from the LoB. In liquid biopsy, LoD is often expressed as a Variant Allele Frequency (VAF) percentage (e.g., 0.1% VAF) or as mutant molecule copies per milliliter of plasma. A robust LoD determination requires accounting for library complexity, Unique Molecular Identifier (UMI) recovery, and the stochastic sampling error inherent to low-input DNA quantities.
LoD Comparison Across Liquid Biopsy Technologies
Comparison of limit of detection capabilities, error suppression mechanisms, and clinical applicability across major liquid biopsy analytical platforms for circulating tumor DNA analysis.
| Feature | Digital Droplet PCR (ddPCR) | NGS with UMIs | Duplex Sequencing |
|---|---|---|---|
Typical LoD (VAF) | 0.01% - 0.1% | 0.1% - 0.5% | 0.001% - 0.01% |
Error Suppression Mechanism | Poisson statistics and partitioning | Molecular barcode consensus | Dual-strand consensus |
Single Nucleotide Variant Detection | |||
Copy Number Alteration Detection | |||
Multiplexing Capacity | 1-5 targets | 50-500+ genes | 50-500+ genes |
Absolute Quantification | |||
Fragmentomics Analysis | |||
Input DNA Required | 1-10 ng | 10-50 ng | 50-100 ng |
Enabling Efficiency, Speed & Accuracy
Intelligent Analysis, Decision & Execution
We build AI systems for teams that need search across company data, workflow automation across tools, or AI features inside products and internal software.
Talk to Us
Search across company data
Give teams answers from docs, tickets, runbooks, and product data with sources and permissions.
Useful when people spend too long searching or get different answers from different systems.

Automate internal workflows
Use AI to route work, draft outputs, trigger actions, and keep approvals and logs in place.
Useful when repetitive work moves across multiple tools and teams.

Add AI to products and internal tools
Build assistants, guided actions, or decision support into the software your team or customers already use.
Useful when AI needs to be part of the product, not a separate tool.
Related Terms
Understanding the Limit of Detection requires familiarity with the molecular biology, error suppression, and quantification techniques that define the analytical floor of a liquid biopsy assay.
Unique Molecular Identifier (UMI)
A random nucleotide barcode ligated to individual DNA molecules before amplification. UMIs enable computational deduplication and error correction by grouping reads sharing the same barcode, allowing the construction of a consensus sequence that cancels out random polymerase errors. Without UMIs, the practical LoD is limited by the error rate of the sequencing chemistry itself.
Variant Allele Frequency (VAF)
The percentage of sequencing reads at a specific genomic locus that carry a variant allele. LoD is often expressed as the minimum VAF at which a variant can be reliably called. Key considerations:
- A VAF of 0.1% corresponds to roughly 1 mutant molecule in 1,000 wild-type molecules
- Low VAF detection requires high library complexity and deep sequencing coverage
- VAF is influenced by both tumor shedding and total cfDNA background
Targeted Error Correction
A bioinformatic strategy that leverages molecular barcodes and redundant sequencing to build consensus sequences, suppressing random polymerase and sequencer errors below the variant detection threshold. By requiring that a variant be observed in multiple independent reads from the same original molecule, error rates can be reduced from ~1% to as low as 10⁻⁵.
Somatic Variant Caller
A specialized algorithm designed to distinguish low-frequency true somatic mutations from germline variants, sequencing errors, and mapping artifacts. Modern callers use probabilistic models that integrate base quality scores, strand bias, and position-specific error rates. The performance of the variant caller directly determines whether the theoretical LoD of the assay can be achieved in practice.
Panel of Normals (PoN)
A curated collection of sequencing data from healthy individuals used to model and suppress systematic technical artifacts and recurrent background noise. By characterizing the baseline noise profile of a specific assay, a PoN enables the variant caller to distinguish true low-frequency mutations from recurrent sequencing artifacts, effectively lowering the achievable LoD without increasing false positives.

About the author
Prasad Kumkar
CEO & MD, Inference Systems
Prasad Kumkar is the CEO & MD of Inference Systems and writes about AI systems architecture, LLM infrastructure, model serving, evaluation, and production deployment. Over 5+ years, he has worked across computer vision models, L5 autonomous vehicle systems, and LLM research, with a focus on taking complex AI ideas into real-world engineering systems.
His work and writing cover AI systems, large language models, AI agents, multimodal systems, autonomous systems, inference optimization, RAG, evaluation, and production AI engineering.
Partnered with leading AI, data, and software stack.
How We Work
Custom AI workflows for your Business
One-fit-all AI don't work for modern businesses. At Inferensys, we aim to understand your business & custom requirements; which we use to define most efficient agentic workflows, the data, and the tools for your business.
01
Review the use case
We understand the task, the users, and where AI can actually help.
Read more02
Pick the right approach
We define what needs search, automation, or product integration.
Read more03
Build the first useful version
We implement the part that proves the value first.
Read more04
Improve from there
We add the checks and visibility needed to keep it useful.
Read moreThe first call is a practical review of your use case and the right next step.
Talk to Us